Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $1,895 | 1 | 65.5% |
| Travel and Lodging | $595.88 | 2 | 20.6% |
| Food and Beverage | $400.28 | 20 | 13.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Arthrex, Inc. | $1,927 | 4 | $0 (2019) |
| Gentleman Orthopedic Solutions | $743.28 | 4 | $0 (2019) |
| Horizon Pharma plc | $155.55 | 12 | $0 (2018) |
| DJO, LLC | $38.89 | 1 | $0 (2023) |
| Novo Nordisk Inc | $14.99 | 1 | $0 (2022) |
| Neos Therapeutics, LP | $11.95 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $38.89 | 1 | DJO, LLC ($38.89) |
| 2022 | $14.99 | 1 | Novo Nordisk Inc ($14.99) |
| 2019 | $2,670 | 8 | Arthrex, Inc. ($1,927) |
| 2018 | $143.05 | 11 | Horizon Pharma plc ($143.05) |
| 2017 | $24.45 | 2 | Horizon Pharma plc ($12.50) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/01/2023 | DJO, LLC | AIRCAST (Device), DONJOY | Food and Beverage | In-kind items and services | $38.89 | General |
| Category: Orthoses: Prefab (non-custom) | ||||||
| 09/01/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Diabetes | ||||||
| 03/29/2019 | Arthrex, Inc. | — | Education | In-kind items and services | $1,895.00 | General |
| 03/29/2019 | Gentleman Orthopedic Solutions | — | Travel and Lodging | In-kind items and services | $373.00 | General |
| 03/29/2019 | Gentleman Orthopedic Solutions | — | Travel and Lodging | In-kind items and services | $222.88 | General |
| 03/29/2019 | Gentleman Orthopedic Solutions | — | Food and Beverage | In-kind items and services | $117.37 | General |
| 03/29/2019 | Gentleman Orthopedic Solutions | — | Food and Beverage | In-kind items and services | $30.03 | General |
| 03/29/2019 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $16.00 | General |
| 03/29/2019 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $12.00 | General |
| 03/29/2019 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $3.50 | General |
| 08/29/2018 | Horizon Pharma plc | VIMOVO (Drug), VIMOVO | Food and Beverage | In-kind items and services | $2.57 | General |
| Category: VIMOVO | ||||||
| 08/08/2018 | Horizon Pharma plc | VIMOVO (Drug), VIMOVO | Food and Beverage | In-kind items and services | $2.82 | General |
| Category: VIMOVO | ||||||
| 07/18/2018 | Horizon Pharma plc | VIMOVO (Drug), VIMOVO | Food and Beverage | In-kind items and services | $1.83 | General |
| Category: VIMOVO | ||||||
| 06/13/2018 | Horizon Pharma plc | VIMOVO (Drug), VIMOVO | Food and Beverage | In-kind items and services | $1.83 | General |
| Category: VIMOVO | ||||||
| 06/01/2018 | Horizon Pharma plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $0.99 | General |
| Category: PENNSAID | ||||||
| 05/11/2018 | Horizon Pharma plc | VIMOVO (Drug), VIMOVO | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: VIMOVO | ||||||
| 04/26/2018 | Horizon Pharma plc | NO_PRODUCT (Drug) | Food and Beverage | In-kind items and services | $122.67 | General |
| Category: NONE | ||||||
| 03/23/2018 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $0.99 | General |
| Category: DUEXIS | ||||||
| 03/06/2018 | Horizon Pharma plc | NO_PRODUCT (Drug) | Food and Beverage | In-kind items and services | $5.46 | General |
| Category: NONE | ||||||
| 02/02/2018 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $2.05 | General |
| Category: DUEXIS | ||||||
| 01/08/2018 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $0.99 | General |
| Category: DUEXIS | ||||||
| 09/11/2017 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: ADHD | ||||||
| 08/10/2017 | Horizon Pharma plc | NO_PRODUCT (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: NONE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 919 | 1,651 | $824,251 | $140,263 |
| 2022 | 9 | 928 | 2,862 | $772,547 | $137,550 |
| 2021 | 9 | 678 | 2,420 | $458,624 | $94,127 |
| 2020 | 5 | 176 | 358 | $94,675 | $15,656 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2023 | 70 | 106 | $232,246 | $57,814 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 189 | 189 | $146,475 | $25,597 | 17.5% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 110 | 139 | $173,455 | $14,497 | 8.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 135 | 179 | $67,125 | $13,599 | 20.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 143 | 143 | $71,500 | $12,444 | 17.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 77 | $38,500 | $7,823 | 20.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 77 | 101 | $81,720 | $6,331 | 7.7% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 70 | 308 | $10,105 | $1,539 | 15.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $2,750 | $579.68 | 21.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 41 | 398 | $374.12 | $38.68 | 10.3% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2022 | 47 | 68 | $148,988 | $40,572 | 27.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 201 | 201 | $155,775 | $26,354 | 16.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 126 | 178 | $66,750 | $14,763 | 22.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 160 | 160 | $80,000 | $14,341 | 17.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 98 | 127 | $157,070 | $13,116 | 8.4% |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 2022 | 16 | 1,248 | $32,822 | $9,822 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 81 | $40,500 | $9,003 | 22.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 70 | 84 | $69,120 | $5,853 | 8.5% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 135 | 715 | $21,522 | $3,726 | 17.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 196 | 196 | $116,125 | $28,068 | 24.2% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2021 | 18 | 23 | $44,137 | $13,982 | 31.7% |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 2021 | 22 | 1,344 | $47,184 | $11,477 | 24.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 83 | 111 | $31,875 | $9,080 | 28.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 95 | 95 | $41,010 | $8,635 | 21.1% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 65 | 79 | $91,085 | $8,177 | 9.0% |
About Dr. James Robinson, MD
Dr. James Robinson, MD is a Sports Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2008. The National Provider Identifier (NPI) number assigned to this provider is 1881857159.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Robinson, MD has received a total of $2,891 in payments from pharmaceutical and medical device companies, with $38.89 received in 2023. These payments were reported across 23 transactions from 6 companies. The most common payment nature is "Education" ($1,895).
As a Medicare-enrolled provider, Robinson has provided services to 2,701 Medicare beneficiaries, totaling 7,291 services with total Medicare billing of $387,596. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Other Specialties Sports Medicine, Sports Medicine
- Location Brooklyn, NY
- Active Since 07/08/2008
- Last Updated 03/25/2021
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1881857159
Products in Payments
- NO_PRODUCT (Drug) $140.63
- AIRCAST (Device) $38.89
- Rybelsus (Drug) $14.99
- Adzenys XR-ODT (Drug) $11.95
- VIMOVO (Drug) $9.90
- DUEXIS (Drug) $4.03
- PENNSAID (Drug) $0.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in Brooklyn
Dr. Olatunde Osofisan, Dpm, DPM
Sports Medicine — Payments: $112,012
Dr. Elizabeth Dennis, Md, Ms, MD, MS
Sports Medicine — Payments: $49,490
Dr. Adam Bier, M.d, M.D
Sports Medicine — Payments: $7,814
Dr. Jonathan Hoskins, M.d, M.D
Sports Medicine — Payments: $7,625
Carl Casimir, Md, MD
Sports Medicine — Payments: $3,993
Alfred Castillo, Do, DO
Sports Medicine — Payments: $3,049